Concepedia

Gertruida Kruger

GK

Statistics

Publications

4

Citations

805

H-Index

4

Active since

2021

Affiliations

Soweto CTC(Current)

Aurum Institute

University of KwaZulu-Natal

University of Cape Town

Novavax (United States)

Gertruida Kruger is an author at Soweto CTC specializing in vaccine surveillance, vaccination, and virology.

Top concepts

Publications per year

2021–2023

4

Publications

4

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 652 citations · Full text

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial

Shabir A. Madhi, Dhayendre Moodley, Sherika Hanley et al. · The Lancet HIV · 2022 · 65 citations · Full text

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson et al. · Scientific Reports · 2023 · 46 citations · Full text

, , +16

Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · 2021 · 42 citations · Full text

, , +16

1–4 of 4